Nutritional Supplement to Treat Macular Degeneration Read more about Nutritional Supplement to Treat Macular Degeneration Germany02728516.2Filed on 2002-03-19
Nutritional Supplement to Treat Macular Degeneration Read more about Nutritional Supplement to Treat Macular Degeneration Austria02728516.2Filed on 2002-03-19
USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE Read more about USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE US Application 11/512,622Filed on 2006-08-30
Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y Read more about Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y European Patent04710659.6Filed on 2004-02-12
Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y Read more about Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y Canada2555792Filed on 2004-02-12
Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y Read more about Therapeutic Administration of the Scrambled Anti-Angiogenic Peptide C16Y Australia2004317159Filed on 2004-02-12
THERAPEUTIC ADMINISTRATION OF THE SCRAMBLED ANTI-ANGIOGENIC PEPTIDE C16Y Read more about THERAPEUTIC ADMINISTRATION OF THE SCRAMBLED ANTI-ANGIOGENIC PEPTIDE C16Y US Patent 8,039,585Filed on 2006-08-09
Ocular Therapeutic Agent Delivery Devices And Methods For Making And Using Such Devices Read more about Ocular Therapeutic Agent Delivery Devices And Methods For Making And Using Such Devices US Application 11/739,540Filed on 2007-04-29
PIGMENT EPITHELIUM DERIVED FACTOR: CHARACTERIZATION OF ITS NOVEL BIOLOGICAL ACTIVITY AND SEQUENCES ENCODING AND EXPRESSING THE PROTEIN Read more about PIGMENT EPITHELIUM DERIVED FACTOR: CHARACTERIZATION OF ITS NOVEL BIOLOGICAL ACTIVITY AND SEQUENCES ENCODING AND EXPRESSING THE PROTEIN Japan2006-33129Filed on 2006-02-09
PEDF-R Receptor And Uses Read more about PEDF-R Receptor And Uses US Application 10/566,540Filed on 2008-11-22